Doxa, Italy’s leading market research and analysis firm, and Connexia, the Group’s data-driven creativity agency, host the third encounter with “WAKE UP INNOVATORS”, a series of monthly meetings about the innovation culture and science.
This month’s special guest is Luca Ravagnan, the CEO and co-founder of the biomedical start-up WISE, the only player on the international market to have developed a proprietary technology that can produce ultrafine, stretchable electrodes which can be implanted during minimally invasive procedures with negligible risk of dislocation, breakage or damage to the host tissues.
The discussion, entitled “WISE: How a mistake in the lab created a medtech start-up”, focuses on the development of the new neural technologies perfected by WISE and will be moderated by Italo Marconi, Connexia’s Chief Innovation Officer. It starts at 8.30 a.m. on Thursday, 20th September, on the sixth floor of the Doxa building.
Based in Milan and Berlin, the medical devices firm is currently experimenting a new generation of electrodes for neuromodulation and neuromonitoring to help cure chronic pain and monitor the brain before and during surgery.